MN
Mads Nikolaj Behrndt-Eriksen
DELAYED 1 MONTH
Chief Financial Officer and General Manager
Hemab Therapeutics Holdings, Inc.
Filings
1
Companies
1
Latest
Jan 29, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.